A study led by Yale Cancer Center found that more men received a prostate-specific antigen (PSA) test to detect prostate cancer following revisions to the recommendation by the U.S. Preventative Services Task Force on screening.
Investigators from UCLA Health found using artificial intelligence to help map out the boundaries of cancerous prostate tissue can significantly reduce the risk of underestimating the extent of prostate cancer—an advancement that can help ensure an accurate diagnosis, precise treatment planning and effective surgical procedures.
